The review integrates 198 references across five domains: (1) anthocyanin chemistry (six common anthocyanidins, pH-dependent equilibrium of flavylium cation, quinonoidal base, carbinol pseudobase and chalcone forms), (2) plant content and agronomic/genetic manipulation, (3) postharvest and processing effects, (4) intake, bioavailability and metabolism, and (5) biological activity spanning cardiovascular, anticancer, antidiabetic, ocular, antimicrobial and neuroprotective effects (). Reported food concentrations span three orders of magnitude, from 1.7 mg/100 g in Red Delicious apple to 1,642 mg/100 g in purple corn.
Figure: reported anthocyanin ranges from the review's Table 1, log scale. Ranges reflect cultivar, environment and method variability the authors explicitly emphasize.
Strengths: The paper is unusually candid about analytical fragility β anthocyanins' pH-dependent speciation and instability may explain anomalously low bioavailability estimates (urinary recovery 0.004β0.2% of intake, up to 5% in one study) (). The authors also flag confounding: most bioactivity studies used fruit/wine extracts, so other phenolics may fully or partially account for effects β a commendable epistemic caveat rare in 2007-era nutraceutical reviews.
Blindspots: (a) The cardiovascular and anticancer sections are dominated by cell-culture and rodent data; the review cites no randomized human intervention outcome trials. (b) Intake estimates vary 60-fold (Kuhnau's 180β215 mg/day vs Chun's 3 mg/day) with no reconciliation beyond population differences β this inconsistency undermines epidemiological anchoring. (c) Anthocyanin quantification methods differ across the cited studies (pH-differential vs HPLC), introducing cross-study measurement bias the paper does not systematically address. (d) The wine section is silent on alcohol-related harms of the primary anthocyanin vehicle. (e) No conflict-of-interest statement appears despite wine- and berry-industry relevance. Later primary literature has partially addressed these gaps: the microbiota-degylcosylation pathway the review flags as unidentified was subsequently confirmed, and bHLH/MYB/WD40 regulation it mentions has since been evolutionarily re-characterized in grasses with an independent ncaMYB/BZ2 module (). Processing-loss data it reviewed (70% canning loss, 40β70% jam losses) remain consistent with later kinetic studies on blackberry blanching (first-order degradation, k = 0.017β0.052 min-1 at 80β100Β°C) ().
The review earns its status as a foundational reference: accurate chemistry, comprehensive agronomy/processing coverage, and honest acknowledgment that "most studies have been done by using fruit extract or wine and thus other substances may be totally or partially responsible" for observed bioactivities. Confidence in its chemical and agronomic content is high; confidence in its extrapolated health-promotion framing is moderate at best given the preponderance of in vitro evidence. What would revise this verdict: well-powered randomized human outcome trials showing no cardiovascular or cancer benefit of isolated anthocyanins, or conversely, metabolite-identified microbiota-mediated effects robust to extract controls.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.